The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES

被引：5
作者：
Salzer, Jonatan [1 ]
机构：
[1] Umea Univ, Neurol Sect, Dept Pharmacol & Clin Neurosci, S-90187 Umea, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷 / 10期
关键词：
BIOMARKERS; MARKER; DAMAGE; LIGHT;
D O I：
10.1177/1352458515578773
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1239 / 1240
页数：2
相关论文
共 10 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]   Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis [J].
Axelsson, Markus ;
Malmestrom, Clas ;
Gunnarsson, Martin ;
Zetterberg, Henrik ;
Sundstrom, Peter ;
Lycke, Jan ;
Svenningsson, Anders .
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (01) :43-50
[3]   Assessing tissue damage in multiple sclerosis: a biomarker approach [J].
Burman, J. ;
Zetterberg, H. ;
Fransson, M. ;
Loskog, A. Sl ;
Raininko, R. ;
Fagius, J. .
ACTA NEUROLOGICA SCANDINAVICA, 2014, 130 (02) :81-89
[4]   EFNS guidelines on disease-specific CSF investigations [J].
Deisenhammer, F. ;
Egg, R. ;
Giovannoni, G. ;
Hemmer, B. ;
Petzold, A. ;
Sellebjerg, F. ;
Teunissen, C. ;
Tumani, H. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (06) :760-770
[5]   Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases [J].
Gaiottino, Johanna ;
Norgren, Niklas ;
Dobson, Ruth ;
Topping, Joanne ;
Nissim, Ahuva ;
Malaspina, Andrea ;
Bestwick, Jonathan P. ;
Monsch, Andreas U. ;
Regeniter, Axel ;
Lindberg, Raija L. ;
Kappos, Ludwig ;
Leppert, David ;
Petzold, Axel ;
Giovannoni, Gavin ;
Kuhle, Jens .
PLOS ONE, 2013, 8 (09)
[6]   Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab [J].
Gunnarsson, Martin ;
Malmestrom, Clas ;
Axelsson, Markus ;
Sundstrom, Peter ;
Dahle, Charlotte ;
Vrethem, Magnus ;
Olsson, Tomas ;
Piehl, Fredrik ;
Norgren, Niklas ;
Rosengren, Lars ;
Svenningsson, Anders ;
Lycke, Jan .
ANNALS OF NEUROLOGY, 2011, 69 (01) :83-89
[7]   Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis [J].
Kuhle, J. ;
Malmestrom, C. ;
Axelsson, M. ;
Plattner, K. ;
Yaldizli, Oe. ;
Derfuss, T. ;
Giovannoni, G. ;
Kappos, L. ;
Lycke, J. .
ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (06) :E33-E36
[8]   Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis [J].
Lycke, JN ;
Karlsson, JE ;
Andersen, O ;
Rosengren, LE .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :402-404
[9]   Neurofilament light as a prognostic marker in multiple sclerosis [J].
Salzer, Jonatan ;
Svenningsson, Anders ;
Sundstrom, Peter .
MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (03) :287-292
[10]   Neurofilaments as biomarkers in multiple sclerosis [J].
Teunissen, Charlotte E. ;
Khalil, Michael .
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (05) :552-556
1